Literature DB >> 17005650

Theiler's murine encephalomyelitis virus leader protein amino acid residue 57 regulates subgroup-specific virus growth on BHK-21 cells.

Masumi Takano-Maruyama1, Yoshiro Ohara, Kunihiko Asakura, Takako Okuwa.   

Abstract

Strains of Theiler's murine encephalomyelitis virus (TMEV) are divided into two subgroups, TO and GDVII. TMEV strains show subgroup-specific virus growth and cell tropism and induce subgroup-specific diseases. Using site-directed mutagenesis, we demonstrated that the amino acid at position 57 of the leader protein (L(57)), which is located at the most N-terminal part of the polyprotein, regulates subgroup-specific virus growth on BHK-21 cells. Further study suggested that L(57) may regulate viral RNA encapsidation, although it does not affect the synthesis of viral proteins or the assembly of viral intermediates.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17005650      PMCID: PMC1676311          DOI: 10.1128/JVI.00693-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

1.  Core protein phosphorylation modulates pregenomic RNA encapsidation to different extents in human and duck hepatitis B viruses.

Authors:  E V Gazina; J E Fielding; B Lin; D A Anderson
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

2.  L* protein of Theiler's murine encephalomyelitis virus is required for virus growth in a murine macrophage-like cell line.

Authors:  M Obuchi; J Yamamoto; T Odagiri; M N Uddin; H Iizuka; Y Ohara
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

3.  The leader polypeptide of Theiler's murine encephalomyelitis virus is required for the assembly of virions in mouse L cells.

Authors:  C Badshah; M A Calenoff; K Rundell
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

Review 4.  Hostile takeovers: viral appropriation of the NF-kappaB pathway.

Authors:  J Hiscott; H Kwon; P Génin
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

5.  Epitope-tagged L* protein of Theiler's murine encephalomyelitis virus is expressed in the central nervous system in the acute phase of infection.

Authors:  Kunihiko Asakura; Harunobu Murayama; Toshiki Himeda; Yoshiro Ohara
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

Review 6.  The survival kinases Akt and Pim as potential pharmacological targets.

Authors:  Ravi Amaravadi; Craig B Thompson
Journal:  J Clin Invest       Date:  2005-10       Impact factor: 14.808

7.  A lentiviral expression system demonstrates that L* protein of Theiler's murine encephalomyelitis virus (TMEV) is essential for virus growth in a murine macrophage-like cell line.

Authors:  Toshiki Himeda; Yoshiro Ohara; Kunihiko Asakura; Yasuhide Kontani; Manabu Murakami; Hiromi Suzuki; Makoto Sawada
Journal:  Virus Res       Date:  2005-03       Impact factor: 3.303

8.  The leader protein of Theiler's virus inhibits immediate-early alpha/beta interferon production.

Authors:  V van Pesch; O van Eyll; T Michiels
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

9.  Cardiovirus leader proteins are functionally interchangeable and have evolved to adapt to virus replication fitness.

Authors:  Sophie Paul; Thomas Michiels
Journal:  J Gen Virol       Date:  2006-05       Impact factor: 3.891

10.  Association of L* protein of Theiler's murine encephalomyelitis virus with microtubules in infected cells.

Authors:  M Obuchi; T Odagiri; K Asakura; Y Ohara
Journal:  Virology       Date:  2001-10-10       Impact factor: 3.616

View more
  9 in total

1.  Different subcellular localization of Theiler's murine encephalomyelitis virus leader proteins of GDVII and DA strains in BHK-21 cells.

Authors:  Naoko Taniura; Mineki Saito; Takako Okuwa; Kousuke Saito; Yoshiro Ohara
Journal:  J Virol       Date:  2009-04-22       Impact factor: 5.103

2.  Apoptotic and antiapoptotic activity of L protein of Theiler's murine encephalomyelitis virus.

Authors:  Spyridon Stavrou; Ghanashyam Ghadge; Raymond P Roos
Journal:  J Virol       Date:  2011-05-11       Impact factor: 5.103

3.  Encephalomyocarditis virus leader is phosphorylated by CK2 and syk as a requirement for subsequent phosphorylation of cellular nucleoporins.

Authors:  Holly A Basta; Valjean R Bacot-Davis; Jessica J Ciomperlik; Ann C Palmenberg
Journal:  J Virol       Date:  2013-12-11       Impact factor: 5.103

4.  African Swine Fever Virus NP868R Capping Enzyme Promotes Reovirus Rescue during Reverse Genetics by Promoting Reovirus Protein Expression, Virion Assembly, and RNA Incorporation into Infectious Virions.

Authors:  Heather E Eaton; Takeshi Kobayashi; Terence S Dermody; Randal N Johnston; Philippe H Jais; Maya Shmulevitz
Journal:  J Virol       Date:  2017-05-12       Impact factor: 5.103

5.  Identification of a novel neuropathogenic Theiler's murine encephalomyelitis virus.

Authors:  Matthew R Buckwalter; Phan Thi Nga; Meriadeg Ar Gouilh; Laurence Fiette; Jean-Francois Bureau; Melissa E Laird; Julian Buchrieser; Simona Ozden; Justine Cheval; Marc Eloit; Jean-Claude Manuguerra; Antoine Gessain; Paul T Brey; Arnaud Fontanet; Matthew L Albert
Journal:  J Virol       Date:  2011-05-04       Impact factor: 5.103

6.  AMP-activated protein kinase phosphorylates EMCV, TMEV and SafV leader proteins at different sites.

Authors:  Holly A Basta; Ann C Palmenberg
Journal:  Virology       Date:  2014-07-05       Impact factor: 3.616

7.  A plasmid-based reverse genetics system for mammalian orthoreoviruses driven by a plasmid-encoded T7 RNA polymerase.

Authors:  Satoshi Komoto; Takahiro Kawagishi; Takeshi Kobayashi; Mine Ikizler; Jason Iskarpatyoti; Terence S Dermody; Koki Taniguchi
Journal:  J Virol Methods       Date:  2013-10-29       Impact factor: 2.014

8.  Virus susceptibility of Chinese hamster ovary (CHO) cells and detection of viral contaminations by adventitious agent testing.

Authors:  Andreas Berting; Maria R Farcet; Thomas R Kreil
Journal:  Biotechnol Bioeng       Date:  2010-07-01       Impact factor: 4.530

9.  Establishment of different plasmid only-based reverse genetics systems for the recovery of African horse sickness virus.

Authors:  Andelé M Conradie; Liesel Stassen; Henk Huismans; Christiaan A Potgieter; Jacques Theron
Journal:  Virology       Date:  2016-09-19       Impact factor: 3.616

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.